http://venturebeat.com/2007/05/17/jazz-pharmaceuticals-sets-ipo-range-aims-to-raise-up-to-1794m/ News About Tech, Money and Innovation Wed, 25 Nov 2009 21:25:26 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/05/17/jazz-pharmaceuticals-sets-ipo-range-aims-to-raise-up-to-1794m/comment-page-1/#comment-401552 VentureBeat » Jazz Pharma ratchets down IPO hopes amid drug controversy Fri, 10 Aug 2007 23:35:02 +0000 http://venturebeat.com/2007/05/17/jazz-pharmaceuticals-sets-ipo-range-aims-to-raise-up-to-1794m/#comment-401552 [...] its wildly overrated strategy of salvaging poorly performing or cast-off drugs from other companies here, so the company’s IPO pullback doesn’t come as a huge surprise. Even at the lower [...] [...] its wildly overrated strategy of salvaging poorly performing or cast-off drugs from other companies here, so the company’s IPO pullback doesn’t come as a huge surprise. Even at the lower [...]

]]>